In a healthcare world increasingly focused on rare and hard-to-treat diseases, cholangiocarcinoma, commonly known as bile duct cancer, is quietly making headlines. Despite its low public awareness, this silent and aggressive cancer is driving significant innovation and investment in its treatment landscape. According to market analysts, the Cholangiocarcinoma Treatment Market is...